*All data from the CDC
Traditional tests require an in-person clinic visit. With primary care visits down especially due to COVID-19, many patients are cancelling their routine screening
Current lipid-based tests have low sensitivity, especially for women.
Coronary calcium screening can expose patients to potentially harmful ionizing radiation.
Current tools use long-term (10-year) windows that do not capture near term risk
The test was validated in patients over the age of 35 who did not have coronary heart disease (CHD). The test is useful for screening patients for risk of CHD, but not for other cardiac conditions such as arrhythmia, heart failure, or aneurysm.
The current output from the test is the 3-year risk of symptomatic CHD characterized as low, intermediate, or high.
If the physician requests the test, the results are sent directly to the physician for disclosure to the patient. If a patient initiates the request for the test through our web portal and requests a telemedicine visit, a copy of the results is released to them by their telemedicine physician.
Currently, the test results from our CLIA certified laboratory are returned approximately 7-10 business days after receipt of the specimen in the lab.
The test (patent pending) measures DNA methylation status at 3 loci and genotype at 5 loci. Then, an artificial intelligence guided algorithm interprets the results of the DNA methylation contextually with respect to the genetic variation. This approach allows us to interpret epigenetic signatures that would otherwise be confounded by background genetic variation. Similar approaches are being used by other epigenetically based tests such as Cologuard®.
The test is approximately twice as sensitive for CHD related events over the 3-year risk window as conventional risk calculators (Framingham Risk Score and ASCVD Risk Calculator). In addition, the content available on our web portal provides guidance for addressing other risk factors for myocardial infarction such as serum cholesterol levels.
Yes. To do so, please email customer service at email@example.com and tell them whether you desire the finger lancet or venipuncture based collection kits. The collection tubes from both kits are shelf stable.